Article

Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis

Avon and Wiltshire Mental Health Partnership NHS Trust, Salisbury, UK.
BMC Psychiatry (Impact Factor: 2.24). 02/2008; 8:51. DOI: 10.1186/1471-244X-8-51
Source: PubMed

ABSTRACT The authors sought to map gray matter changes in Attention Deficit Hyperactivity Disorder (ADHD) using a novel technique incorporating neuro-imaging and genetic meta-analysis methods.
A systematic search was conducted for voxel-based structural magnetic resonance imaging studies of patients with ADHD (or with related disorders) in relation to comparison groups. The authors carried out meta-analyses of the co-ordinates of gray matter differences. For the meta-analyses they hybridised the standard method of Activation Likelihood Estimation (ALE) with the rank approach used in Genome Scan Meta-Analysis (GSMA). This system detects three-dimensional conjunctions of co-ordinates from multiple studies and permits the weighting of studies in relation to sample size.
For gray matter decreases, there were 7 studies including a total of 114 patients with ADHD (or related disorders) and 143 comparison subjects. Meta-analysis of these studies identified a significant regional gray matter reduction in ADHD in the right putamen/globus pallidus region. Four studies reported gray matter increases in ADHD but no regional increase was identified by meta-analysis.
In ADHD there is gray matter reduction in the right putamen/globus pallidus region. This may be an anatomical marker for dysfunction in frontostriatal circuits mediating cognitive control. Right putamen lesions have been specifically associated with ADHD symptoms after closed head injuries in children.

Full-text

Available from: Edward T Bullmore, Apr 19, 2015
1 Follower
 · 
95 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The object of the current study is to explore the neural substrate for effects of atomoxetine (ATX) on inhibitory control in school-aged children with attention deficit hyperactivity disorder (ADHD) using functional near-infrared spectroscopy (fNIRS). We monitored the oxy-hemoglobin signal changes of sixteen ADHD children (6–14 years old) performing a go/no-go task before and 1.5 h after ATX or placebo administration, in a randomized, double-blind, placebo-controlled, crossover design. Sixteen age- and gender-matched normal controls without ATX administration were also monitored. In the control subjects, the go/no-go task recruited the right inferior and middle prefrontal gyri (IFG/MFG), and this activation was absent in pre-medicated ADHD children. The reduction of right IFG/MFG activation was acutely normalized after ATX administration but not placebo administration in ADHD children. These results are reminiscent of the neuropharmacological effects of methylphenidate to up-regulate reduced right IFG/MFG function in ADHD children during inhibitory tasks. As with methylphenidate, activation in the IFG/MFG could serve as an objective neuro-functional biomarker to indicate the effects of ATX on inhibitory control in ADHD children. This promising technique will enhance early clinical diagnosis and treatment of ADHD in children, especially in those with a hyperactivity/impulsivity phenotype.
    01/2014; 6. DOI:10.1016/j.nicl.2014.09.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obsessive compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD) are two of the most common neuropsychiatric diseases in paediatric populations. The high comorbidity of ADHD and OCD with each other, especially of ADHD in paediatric OCD, is well described. OCD and ADHD often follow a chronic course with persistent rates of at least 40-50 %. Family studies showed high heritability in ADHD and OCD, and some genetic findings showed similar variants for both disorders of the same pathogenetic mechanisms, whereas other genetic findings may differentiate between ADHD and OCD. Neuropsychological and neuroimaging studies suggest that partly similar executive functions are affected in both disorders. The deficits in the corresponding brain networks may be responsible for the perseverative, compulsive symptoms in OCD but also for the disinhibited and impulsive symptoms characterizing ADHD. This article reviews the current literature of neuroimaging, neurochemical circuitry, neuropsychological and genetic findings considering similarities as well as differences between OCD and ADHD.
    ADHD Attention Deficit and Hyperactivity Disorders 07/2014; 6(3). DOI:10.1007/s12402-014-0146-x
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Le trouble déficitaire de l'attention avec hyperactivité (TDAH) est une affection neuropsychiatrique extrêmement courante pendant l'enfance. On estime qu'elle touche 3 à 7 % des enfants d'âge scolaire à l'échelle mondiale. 1 En raison des symptômes de ce trouble et des comorbidités d'ordre psychiatrique qui y sont fréquemment associés, les personnes qui en souffrent peuvent être exposées à des conflits familiaux, des relations médiocres avec leurs pairs et des échecs scolaires ou professionnels. Par conséquent, le TDAH représente un fardeau énorme pour la société. 2 Problèmes • Actuellement, on diagnostique le TDAH selon un ensemble de critères comportementaux; 1 cette « subjectivité » dans le diagnostic favorise la controverse. • La présentation clinique des sujets qui souffrent d'un TDAH peut varier, ce qui crée de la confusion dans les milieux cliniques ainsi que dans ceux de la recherche. • La classification actuelle ne tient pas compte des variations des symptômes qui apparaissent au cours du développement. • Actuellement, aucun traitement curatif à long terme n'est disponible. 3 Sujet Les découvertes du domaine naissant qu'est la neuroscience pédiatrique seront nécessaires pour passer de la classification fondée sur la description clinique des symptômes à un modèle basé sur les causes du trouble. Un tel modèle mécaniste est susceptible de mener à une caractérisation objective des patients par une définition plus précise des sous-types du TDAH ainsi qu'à une éventuelle mise au point de traitements efficaces basés sur la pathophysiologie.